Products for Research Use Only
RegisterLogin

DOTA-XYIMSR-01

CAT: 0013-GTR19338543-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19338543-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DOTA-XYIMSR-01 is a molecular probe targeting CAIX, capable of being labeled with 177Lu for the treatment and localization of malignant gliomas. The uptake of [177Lu]Lu-XYIMSR-01 in U87MG tumors is 6.19% injected dose per gram (% ID/g), with a tumor-to-muscle uptake ratio of 20.14. In an orthotopic glioma model, co-administration with temozolomide significantly enhances survival rates and inhibits tumor growth in mice. DOTA-XYIMSR-01 shows potential for research in the field of cancer treatment.
CAS Number
2051527-54-7
Field of Research
Metabolism Research
Molecular Weight
1461.57
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR19264979-01DOTA-ALB-01
GTR19144455-01DOTA-PSMA-EB-01
GTR19267069-01DOTA-Tyr-Lys-DOTA
GTR19278512-01Janus-DOTA
GTR19248036-01Butyne-DOTA
GTR19248018-01DOTA-Thiol
GTR19193571Lysine-DOTA
GTR19189931Maleimide-DOTA
GTR19259587DOTA-Octreotide
GTR19248032-01DOTA-amide

Alternative Products

CatalogName
HY-173116DOTA-XYIMSR-01
T212294-01DOTA-ALB-01
TP3571-01DOTA-PSMA-EB-01
TRC-D535500-250MGDOTA
TYD-02727-01DOTA-Tyr-Lys-DOTA
BA5818-1DOTA-LM3
HY-P11254DOTA-FAPT
4029066.0250DOTA (OtBu) ₃
4029066.05DOTA(OtBu)₃
HY-W678394-01DOTA-Thiol

Popular Products